Developing selective small-molecule modulators of

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH OLAO

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98026Q00988

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

Q301

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a solicitation (Procurement Identifier: 75N98026Q00988) seeking proposals for the development of selective small-molecule modulators. This procurement is structured as a combined synopsis/solicitation for commercial items, in accordance with FAR Subpart 12.6, and is intended to streamline the acquisition process for commercial products or services. The solicitation is open to full and open competition, with no set-aside restrictions, and is anticipated to result in a firm-fixed-price contract or purchase order awarded to the offeror whose proposal represents the best value to the Government. The scope of this procurement centers on research and development activities within the physical, engineering, and life sciences domains, specifically excluding nanotechnology and biotechnology. The associated NAICS code is 541715, with a small business size standard of 1,000 employees. The requirement is unrestricted, allowing participation from both small and large businesses that possess the requisite expertise and capacity. The primary objective of this solicitation is to identify and engage a contractor capable of developing selective small-molecule modulators. While the notice does not provide detailed technical specifications or deliverable requirements, it is clear that the NIH seeks commercial solutions that can advance research in this specialized area. Contractors should be prepared to demonstrate their capabilities in small-molecule development, including relevant experience, technical approach, and the ability to deliver high-quality, innovative solutions within the prescribed timeline and budget. The solicitation incorporates all applicable provisions and clauses as of the Federal Acquisition Circular effective August 7, 2026. Interested parties should note that the acquisition is conducted under the authority of FAR 12.603, which allows for streamlined solicitation procedures for commercial products and services. The anticipated contract value is not expected to exceed the simplified acquisition threshold, making this an accessible opportunity for qualified vendors. The contracting entity for this opportunity is the National Institutes of Health OLAO, a federal office within the Department of Health and Human Services. The primary point of contact for this solicitation is Jaddua C. Johnston, who can be reached via email at [email protected]. The notice was posted on August 18, 2026, with a response deadline of August 24, 2026. Contractors evaluating this opportunity should consider their alignment with the NIH’s research and development objectives, their capacity to deliver commercial solutions in the field of small-molecule modulation, and their ability to comply with federal acquisition regulations. The procurement is classified under Product Service Code Q301, further emphasizing its focus on research and development services. For additional details, interested parties are encouraged to review the solicitation and any associated attachments available through the official notice on SAM.gov (Opportunity ID: 7f9cbf9a66bf46269583ec283f61fdac). This opportunity represents a significant engagement for organizations specializing in advanced research and development within the life sciences, offering the potential to contribute to critical NIH initiatives through the development of innovative small-molecule modulators.